$1.29 Billion is the total value of Perceptive Advisors's 160 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 70.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
FOLD | AMICUS THERAPEUTICS INC | $157,101,000 | +30.8% | 14,439,444 | 0.0% | 12.21% | +21.2% | |
NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $148,566,000 | +86.5% | 3,741,267 | +4.9% | 11.54% | +72.9% |
RTRX | Buy | RETROPHIN INC | $66,728,000 | +180.9% | 2,784,980 | +43.5% | 5.19% | +160.3% |
TSRO | Buy | TESARO INC | $56,158,000 | +70.9% | 978,359 | +10.8% | 4.36% | +58.4% |
RLYP | Buy | RELYPSA INC | $52,451,000 | +37.4% | 1,454,142 | +17.4% | 4.08% | +27.3% |
LBIO | Sell | LION BIOTECHNOLOGIES INC | $32,873,000 | +29.9% | 2,714,549 | -15.6% | 2.56% | +20.4% |
XNCR | Buy | XENCOR INC | $29,947,000 | -3.1% | 1,954,785 | +1.4% | 2.33% | -10.2% |
DYAX | Sell | DYAX CORP | $29,774,000 | +14.3% | 1,777,000 | -4.0% | 2.31% | +6.0% |
SRPT | Sell | SAREPTA THERAPEUTICS INC | $29,278,000 | -28.1% | 2,204,652 | -21.6% | 2.28% | -33.3% |
NVRO | Buy | NEVRO CORP | $26,700,000 | +291.0% | 557,056 | +215.5% | 2.08% | +262.1% |
ACRX | ACELRX PHARMACEUTICALS INC | $25,376,000 | -42.6% | 6,574,060 | 0.0% | 1.97% | -46.8% | |
QURE | Buy | UNIQURE NV | $25,227,000 | +769.6% | 1,039,332 | +430.7% | 1.96% | +706.6% |
BLCM | BELLICUM PHARMACEUTICALS INC | $24,245,000 | +0.6% | 1,046,402 | 0.0% | 1.88% | -6.8% | |
VSAR | Buy | VERSARTIS INC | $24,161,000 | +22.4% | 1,546,471 | +66.1% | 1.88% | +13.5% |
ZBH | Buy | ZIMMER HLDGS INC | $21,247,000 | +21.6% | 180,793 | +17.3% | 1.65% | +12.6% |
CEMP | Buy | CEMPRA INC | $19,642,000 | +237.5% | 572,500 | +131.3% | 1.53% | +212.7% |
RCPT | Sell | RECEPTOS INC | $19,588,000 | -45.1% | 118,794 | -59.2% | 1.52% | -49.2% |
ACAD | Sell | ACADIA PHARMACEUTICALS INC | $19,562,000 | -43.6% | 600,240 | -45.1% | 1.52% | -47.8% |
ANIP | Sell | ANI PHARMACEUTICALS INC | $19,252,000 | +9.2% | 307,784 | -1.5% | 1.50% | +1.2% |
OTIC | Buy | OTONOMY INC | $16,986,000 | +12.2% | 480,387 | +5.7% | 1.32% | +3.9% |
BLUE | Sell | BLUEBIRD BIO INC | $16,304,000 | -21.0% | 135,000 | -40.0% | 1.27% | -26.8% |
CSU | Buy | CAPITAL SR LIVING CORP | $15,694,000 | +152.0% | 605,000 | +142.0% | 1.22% | +133.7% |
B108PS | Buy | ACTAVIS PLC | $14,638,000 | +276.9% | 49,185 | +226.0% | 1.14% | +249.1% |
PFNX | Buy | PFENEX INC | $13,811,000 | +366.3% | 866,423 | +114.1% | 1.07% | +332.7% |
PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $13,476,000 | +1803.4% | 355,000 | +1320.0% | 1.05% | +1674.6% |
XLRN | Buy | ACCELERON PHARMA INC | $12,790,000 | +3.4% | 336,036 | +5.8% | 0.99% | -4.2% |
THOR | Sell | THORATEC CORP | $12,567,000 | -1.4% | 300,000 | -23.6% | 0.98% | -8.5% |
SGMO | SANGAMO BIOSCIENCES INC | $12,544,000 | +3.1% | 800,000 | 0.0% | 0.98% | -4.4% | |
INSM | Sell | INSMED INC | $12,185,000 | +14.8% | 585,812 | -14.6% | 0.95% | +6.4% |
NEPT | NEPTUNE TECHNOLOGIES BIORESO | $10,935,000 | -14.7% | 6,750,444 | 0.0% | 0.85% | -21.0% | |
QTNT | Buy | QUOTIENT LTD | $10,702,000 | +31.0% | 550,870 | +21.4% | 0.83% | +21.5% |
AEGR | New | AEGERION PHARMACEUTICALS INC | $9,973,000 | – | 381,100 | +100.0% | 0.78% | – |
SRPT | Buy | Sarepta Therapeutics Inccall | $9,960,000 | +52.9% | 750,000 | +66.7% | 0.77% | +41.8% |
ELGX | Buy | ENDOLOGIX INC | $9,645,000 | +200.4% | 565,000 | +169.0% | 0.75% | +178.8% |
CLDN | New | CELADON GROUP INCcall | $8,987,000 | – | 474,500 | +100.0% | 0.70% | – |
ANI PHARMACEUTICALS INCnote 3.000%12/0 | $8,621,000 | +9.3% | 7,500,000 | 0.0% | 0.67% | +1.4% | ||
ZSPH | New | ZS PHARMA INC | $7,860,000 | – | 186,777 | +100.0% | 0.61% | – |
BIIB | New | BIOGEN INC | $7,685,000 | – | 18,200 | +100.0% | 0.60% | – |
SHPG | Buy | SHIRE PLCsponsored adr | $7,179,000 | +237.8% | 30,000 | +200.0% | 0.56% | +213.5% |
ANTH | Buy | ANTHERA PHARMACEUTICALS INC | $7,166,000 | +801.4% | 1,603,156 | +218.6% | 0.56% | +731.3% |
VBIV | New | VBI VACCINES INC. | $6,786,000 | – | 2,610,356 | +100.0% | 0.53% | – |
DYAX | New | DYAX CORPput | $6,702,000 | – | 400,000 | +100.0% | 0.52% | – |
CBPO | Sell | CHINA BIOLOGIC PRODS INC | $6,686,000 | +34.3% | 70,000 | -5.4% | 0.52% | +24.7% |
New | SUPERNUS PHARMACEUTICALSinc note 7.500% | $6,650,000 | – | 2,915,000 | +100.0% | 0.52% | – | |
AGTC | APPLIED GENETIC TECHNOL CO | $6,021,000 | -4.9% | 301,222 | 0.0% | 0.47% | -11.9% | |
ALLIQUA BIOMEDIC | $5,834,000 | -1.9% | 1,121,951 | 0.0% | 0.45% | -9.2% | ||
ASMB | New | ASSEMBLY BIOSCIENCES INC | $5,627,000 | – | 425,000 | +100.0% | 0.44% | – |
TKAI | Sell | TOKAI PHARMACEUTICALS INC | $5,484,000 | -23.3% | 458,338 | -5.6% | 0.43% | -29.0% |
CPRX | New | CATALYST PHARM PARTNERS INC | $5,196,000 | – | 1,200,000 | +100.0% | 0.40% | – |
MDGN | Buy | MEDGENICS INC | $5,146,000 | +97.8% | 639,225 | +24.3% | 0.40% | +83.5% |
FPRX | Buy | FIVE PRIME THERAPEUTICS IN | $5,121,000 | +22.2% | 224,129 | +44.4% | 0.40% | +13.1% |
AFMD | Sell | AFFIMED N V | $5,076,000 | -18.6% | 805,820 | -19.9% | 0.39% | -24.7% |
TARO | Sell | TARO PHARMACEUTICAL INDS LTD | $4,736,000 | -79.3% | 33,574 | -78.2% | 0.37% | -80.8% |
NEURODERM LTD | $4,697,000 | -4.4% | 350,000 | 0.0% | 0.36% | -11.4% | ||
LJPC | Sell | LA JOLLA PHARMACEUTICAL CO | $4,628,000 | -13.2% | 252,915 | -12.5% | 0.36% | -19.5% |
ALDR | New | ALDER BIOPHARMACEUTICALS INC | $4,329,000 | – | 150,000 | +100.0% | 0.34% | – |
THOR | THORATEC CORPcall | $4,189,000 | +29.1% | 100,000 | 0.0% | 0.33% | +19.9% | |
ARDX | Buy | ARDELYX INC | $4,136,000 | -14.4% | 315,955 | +23.6% | 0.32% | -20.7% |
NERV | New | MINERVA NEUROSCIENCES | $4,052,000 | – | 810,537 | +100.0% | 0.32% | – |
PTBI | PLASMATECH BIOPHARMACEUTICAL | $3,925,000 | -10.3% | 1,250,000 | 0.0% | 0.30% | -16.9% | |
TRXC | Sell | TRANSENTERIX INC | $3,893,000 | -36.2% | 1,328,668 | -36.6% | 0.30% | -40.7% |
XENE | XENON PHARMACEUTICALS INC | $3,795,000 | -14.6% | 225,000 | 0.0% | 0.30% | -20.9% | |
HCA | Buy | HCA HOLDINGS INC | $3,762,000 | +5.4% | 50,000 | +2.8% | 0.29% | -2.3% |
TTPH | TETRAPHASE PHARMACEUTICALS I | $3,664,000 | -7.7% | 100,000 | 0.0% | 0.28% | -14.4% | |
ALDX | New | ALDEYRA THERAPEUTICS | $3,634,000 | – | 357,000 | +100.0% | 0.28% | – |
SAGE | SAGE THERAPEUTICS INC | $3,540,000 | +37.2% | 70,484 | 0.0% | 0.28% | +27.3% | |
CELG | Sell | CELGENE CORP | $3,455,000 | -78.9% | 29,967 | -79.6% | 0.27% | -80.5% |
MGNX | Sell | MACROGENICS INC | $3,332,000 | -56.0% | 106,208 | -50.8% | 0.26% | -59.2% |
PRTO | PROTEON THERAPEUTICS INC | $3,198,000 | +11.8% | 275,000 | 0.0% | 0.25% | +3.8% | |
CSBR | Buy | CHAMPIONS ONCOLOGY | $3,082,000 | +279.6% | 4,403,680 | +170.9% | 0.24% | +252.9% |
PCYC | New | PHARMACYCLICS INC | $3,071,000 | – | 12,000 | +100.0% | 0.24% | – |
RDUS | New | RADIUS HEALTH INC | $3,046,000 | – | 74,000 | +100.0% | 0.24% | – |
RGEN | REPLIGEN CORPput | $3,036,000 | +53.3% | 100,000 | 0.0% | 0.24% | +42.2% | |
DSCI | Buy | DERMA SCIENCES INC | $2,908,000 | -0.4% | 343,284 | +9.5% | 0.23% | -7.8% |
RPTP | New | RAPTOR PHARMACEUTICAL CORP | $2,872,000 | – | 264,200 | +100.0% | 0.22% | – |
NVTA | New | INVITAE CORP | $2,765,000 | – | 165,000 | +100.0% | 0.22% | – |
IMMU | New | IMMUNOMEDICS INCput | $2,625,000 | – | 600,000 | +100.0% | 0.20% | – |
CHRS | Sell | COHERUS BIOSCIENCES INC | $2,608,000 | -63.5% | 85,288 | -80.5% | 0.20% | -66.1% |
MGCD | MGC DIAGNOSTICS CORP | $2,475,000 | +15.0% | 336,287 | 0.0% | 0.19% | +6.7% | |
HEWG | New | ISHARES TRhdg msci germn | $2,426,000 | – | 85,000 | +100.0% | 0.19% | – |
DERM | DERMIRA INC | $2,333,000 | -15.3% | 152,000 | 0.0% | 0.18% | -21.6% | |
VCEL | Sell | VERICEL CORP | $2,180,000 | -15.6% | 589,297 | -30.7% | 0.17% | -22.1% |
CLDN | New | CELADON GROUP INCput | $1,894,000 | – | 100,000 | +100.0% | 0.15% | – |
GNVC | Sell | GENVEC INC | $1,811,000 | -18.6% | 615,844 | -40.8% | 0.14% | -24.6% |
BCLI | New | BRAINSTORM CELL THERAPEUTICS | $1,780,000 | – | 400,000 | +100.0% | 0.14% | – |
DRRX | DURECT CORP | $1,732,000 | +141.9% | 907,064 | 0.0% | 0.14% | +125.0% | |
WBA | WALGREENS BOOTS ALLIANCE INC | $1,719,000 | +11.2% | 20,292 | 0.0% | 0.13% | +3.1% | |
SNSS | Buy | SUNESIS PHARMACEUTICALS INC | $1,715,000 | +34.5% | 700,000 | +40.0% | 0.13% | +24.3% |
ONTY | Buy | ONCOTHYREON INC | $1,508,000 | +144.0% | 925,000 | +184.6% | 0.12% | +125.0% |
TCON | New | TRACON PHARMACEUTICALS INC | $1,404,000 | – | 100,000 | +100.0% | 0.11% | – |
PSDV | PSIVIDA CORP | $1,244,000 | -3.9% | 315,000 | 0.0% | 0.10% | -11.0% | |
AVGR | New | AVINGER INC | $1,248,000 | – | 112,500 | +100.0% | 0.10% | – |
UPI | Buy | UROPLASTY INC | $1,179,000 | -25.3% | 966,349 | +26.1% | 0.09% | -30.3% |
New | ARNO THERAPEUTICS INC | $1,179,000 | – | 2,034,721 | +100.0% | 0.09% | – | |
PTBIW | PLASMATECH BIOPHARMACEUTICAL*w exp 10/24/201 | $1,163,000 | +16.3% | 1,250,000 | 0.0% | 0.09% | +7.1% | |
ONCE | New | SPARK THERAPEUTICS INC | $1,163,000 | – | 15,000 | +100.0% | 0.09% | – |
ALIM | Sell | ALIMERA SCIENCES INC | $1,161,000 | -45.1% | 231,900 | -39.3% | 0.09% | -49.2% |
STML | New | STEMLINE THERAPEUTICS INC | $1,147,000 | – | 79,245 | +100.0% | 0.09% | – |
ACST | Sell | ACASTI PHARMA INC | $1,134,000 | -11.8% | 2,365,600 | -8.1% | 0.09% | -18.5% |
AQXP | AQUINOX PHARMACEUTICALS IN | $1,115,000 | +14.4% | 130,000 | 0.0% | 0.09% | +6.1% | |
KERX | New | KERYX BIOPHARMACEUTICALS INC | $1,074,000 | – | 84,380 | +100.0% | 0.08% | – |
GILD | New | GILEAD SCIENCES INC | $981,000 | – | 10,000 | +100.0% | 0.08% | – |
PARNF | Sell | PARNELL PHARMACEUT HLDGS | $964,000 | +8.6% | 196,500 | -8.2% | 0.08% | +1.4% |
AGEN | Sell | AGENUS INC | $929,000 | -41.9% | 181,117 | -55.0% | 0.07% | -46.3% |
VNDA | VANDA PHARMACEUTICALS INCput | $930,000 | -35.1% | 100,000 | 0.0% | 0.07% | -40.0% | |
VNDA | Sell | VANDA PHARMACEUTICALS INCcall | $930,000 | -89.2% | 100,000 | -83.3% | 0.07% | -90.0% |
INCY | New | INCYTE CORP | $917,000 | – | 10,000 | +100.0% | 0.07% | – |
INFI | Buy | INFINITY PHARMACEUTICALS INC | $853,000 | +229.3% | 61,000 | +298.1% | 0.07% | +200.0% |
ABMD | New | ABIOMED INC | $716,000 | – | 10,000 | +100.0% | 0.06% | – |
GLMD | GALMED PHARMACEUTICALS LTD | $706,000 | +62.3% | 75,000 | 0.0% | 0.06% | +52.8% | |
IMPR | New | IMPRIVATA INC | $700,000 | – | 50,000 | +100.0% | 0.05% | – |
ASPX | New | AUSPEX PHARMACEUTICALS INC | $602,000 | – | 6,000 | +100.0% | 0.05% | – |
AKAOQ | ACHAOGEN INC | $586,000 | -25.2% | 60,000 | 0.0% | 0.05% | -30.3% | |
ILMN | New | ILLUMINA INC | $531,000 | – | 2,859 | +100.0% | 0.04% | – |
EGRX | New | EAGLE PHARMACEUTICALS INC | $506,000 | – | 12,088 | +100.0% | 0.04% | – |
BVX | New | BOVIE MEDICAL CORP | $478,000 | – | 200,000 | +100.0% | 0.04% | – |
THC | Sell | TENET HEALTHCARE CORP | $449,000 | -88.3% | 8,500 | -88.8% | 0.04% | -89.2% |
MDT | New | MEDTRONIC PLC | $390,000 | – | 5,000 | +100.0% | 0.03% | – |
MRGE | MERGE HEALTHCARE INC | $368,000 | +25.6% | 82,427 | 0.0% | 0.03% | +16.0% | |
ARIA | New | ARIAD PHARMACEUTICALS INC | $346,000 | – | 41,949 | +100.0% | 0.03% | – |
HPTX | New | HYPERION THERAPEUTICS INC | $317,000 | – | 6,913 | +100.0% | 0.02% | – |
MYL | New | MYLAN N V | $305,000 | – | 5,133 | +100.0% | 0.02% | – |
LCI | LANNET INC | $297,000 | +58.0% | 4,392 | 0.0% | 0.02% | +43.8% | |
CBM | Sell | CAMBREX CORP | $291,000 | +17.3% | 7,331 | -36.2% | 0.02% | +9.5% |
AET | AETNA INC NEW | $275,000 | +19.6% | 2,586 | 0.0% | 0.02% | +10.5% | |
GB | New | GREATBATCH INC | $254,000 | – | 4,391 | +100.0% | 0.02% | – |
UTHR | New | UNITED THERAPEUTICS CORP DEL | $255,000 | – | 1,481 | +100.0% | 0.02% | – |
UHS | UNIVERSAL HLTH SVCS INCcl b | $263,000 | +6.0% | 2,233 | 0.0% | 0.02% | -4.8% | |
CI | Sell | CIGNA CORPORATION | $255,000 | +11.8% | 1,970 | -11.2% | 0.02% | +5.3% |
WCG | New | WELLCARE HEALTH PLANS INC | $246,000 | – | 2,690 | +100.0% | 0.02% | – |
HNT | Sell | HEALTH NET INC | $249,000 | -7.4% | 4,109 | -18.2% | 0.02% | -17.4% |
SCAI | Sell | SURGICAL CARE AFFILIATES | $241,000 | -6.9% | 7,020 | -8.9% | 0.02% | -13.6% |
LH | New | LABORATORY CORP AMER HLDGS | $247,000 | – | 1,956 | +100.0% | 0.02% | – |
PAHC | Sell | PHIBRO ANIMAL HEALTH CORP | $241,000 | +1.7% | 6,809 | -9.5% | 0.02% | -5.0% |
CAH | New | CARDINAL HEALTH INC | $232,000 | – | 2,574 | +100.0% | 0.02% | – |
MCK | New | MCKESSON CORP | $230,000 | – | 1,015 | +100.0% | 0.02% | – |
RAD | Sell | RITE AID CORP | $218,000 | -31.4% | 25,063 | -40.9% | 0.02% | -37.0% |
LPNT | New | LIFEPOINT HOSPITALS INC | $222,000 | – | 3,025 | +100.0% | 0.02% | – |
RDNT | New | RADNET INC | $223,000 | – | 26,525 | +100.0% | 0.02% | – |
ICLR | New | ICON PLC | $204,000 | – | 2,898 | +100.0% | 0.02% | – |
EXAC | Sell | EXACTECH INC | $203,000 | -17.1% | 7,905 | -23.8% | 0.02% | -23.8% |
CTLT | New | CATALENT INC | $200,000 | – | 6,429 | +100.0% | 0.02% | – |
GTS | TRIPLE-S MGMT CORPcl b | $211,000 | -16.9% | 10,605 | 0.0% | 0.02% | -23.8% | |
MGLN | New | MAGELLAN HEALTH INC | $205,000 | – | 2,900 | +100.0% | 0.02% | – |
CYTK | New | CYTOKINETICS INC | $205,000 | – | 30,227 | +100.0% | 0.02% | – |
AMSG | New | AMSURG CORP | $205,000 | – | 3,328 | +100.0% | 0.02% | – |
BKD | New | BROOKDALE SR LIVING INC | $189,000 | – | 5,000 | +100.0% | 0.02% | – |
LHCG | Sell | LHC GROUP INC | $195,000 | -35.4% | 5,917 | -38.9% | 0.02% | -40.0% |
OXGN | OXIGENE INC | $180,000 | -9.5% | 123,518 | 0.0% | 0.01% | -17.6% | |
ASND | New | ASCENDIS PHARMA A Ssponsored adr | $174,000 | – | 10,000 | +100.0% | 0.01% | – |
SURG | New | SYNERGETICS USA INC | $117,000 | – | 21,786 | +100.0% | 0.01% | – |
CLLS | New | CELLECTIS S Asponsored ads | $52,000 | – | 1,500 | +100.0% | 0.00% | – |
CAPR | New | CAPRICOR THERAPEUTICS INC | $35,000 | – | 4,000 | +100.0% | 0.00% | – |
ESPR | Sell | ESPERION THERAPEUTICS INC NE | $9,000 | -99.9% | 102 | -100.0% | 0.00% | -99.9% |
ICEL | CELLULAR DYNAMICS INTL INC | $3,000 | +200.0% | 164 | 0.0% | 0.00% | – | |
MNKD | New | MANNKIND CORPcall | $1,000 | – | 100 | +100.0% | 0.00% | – |
DBVT | Sell | DBV TECHNOLOGIES S Asponsored adr | $0 | -100.0% | 2 | -100.0% | 0.00% | -100.0% |
TBIO | Sell | TRANSGENOMIC INC | $1,000 | -99.6% | 357 | -99.7% | 0.00% | -100.0% |
XOMA | Exit | XOMA LTDcall | $0 | – | -200 | -100.0% | 0.00% | – |
SGEN | Exit | SEATTLE GENETICS INC /WAcall | $0 | – | -900 | -100.0% | -0.00% | – |
OHRP | Exit | OHR PHARMACEUTICAL INC | $0 | – | -6,000 | -100.0% | -0.00% | – |
SEM | Exit | SELECT MED HLDGS CORP | $0 | – | -13,365 | -100.0% | -0.02% | – |
SUPN | Exit | SUPERNUS PHARMACEUTICALS INC | $0 | – | -22,285 | -100.0% | -0.02% | – |
USPH | Exit | U S PHYSICAL THERAPY INC | $0 | – | -5,156 | -100.0% | -0.02% | – |
PRXL | Exit | PAREXEL INTL CORP | $0 | – | -4,005 | -100.0% | -0.02% | – |
BCR | Exit | BARD C R INC | $0 | – | -1,367 | -100.0% | -0.02% | – |
CIVI | Exit | CIVITAS SOLUTIONS INC | $0 | – | -13,585 | -100.0% | -0.02% | – |
PDLI | Exit | PDL BIOPHARMA INC | $0 | – | -30,151 | -100.0% | -0.02% | – |
BSTC | Exit | BIOSPECIFICS TECHNOLOGIES CO | $0 | – | -6,065 | -100.0% | -0.02% | – |
CYBX | Exit | CYBERONICS INC | $0 | – | -4,454 | -100.0% | -0.02% | – |
SKH | Exit | SKILLED HEALTHCARE GROUP INCcl a | $0 | – | -31,293 | -100.0% | -0.02% | – |
CNC | Exit | CENTENE CORP DEL | $0 | – | -2,484 | -100.0% | -0.02% | – |
SCLN | Exit | SCICLONE PHARMACEUTICALS INC | $0 | – | -29,942 | -100.0% | -0.02% | – |
NSPH | Exit | NANOSPHERE INC | $0 | – | -707,566 | -100.0% | -0.02% | – |
CLVS | Exit | CLOVIS ONCOLOGY INC | $0 | – | -5,138 | -100.0% | -0.02% | – |
GALE | Exit | GALENA BIOPHARMA INCput | $0 | – | -200,000 | -100.0% | -0.02% | – |
THLD | Exit | THRESHOLD PHARMACEUTICAL INC | $0 | – | -160,000 | -100.0% | -0.04% | – |
SPNC | Exit | SPECTRANETICS CORP | $0 | – | -16,335 | -100.0% | -0.05% | – |
SIEN | Exit | SIENTRA INC | $0 | – | -37,000 | -100.0% | -0.05% | – |
HIIQ | Exit | HEALTH INS INNOVATIONS INC | $0 | – | -96,000 | -100.0% | -0.06% | – |
MNKD | Exit | MANNKIND CORPput | $0 | – | -200,000 | -100.0% | -0.09% | – |
ACHN | Exit | ACHILLION PHARMACEUTICALS IN | $0 | – | -106,100 | -100.0% | -0.11% | – |
ELOS | Exit | SYNERON MEDICAL LTD | $0 | – | -152,609 | -100.0% | -0.12% | – |
CLDX | Exit | CELLDEX THERAPEUTICS INC NEW | $0 | – | -100,000 | -100.0% | -0.15% | – |
ABMD | Exit | ABIOMED INCcall | $0 | – | -50,000 | -100.0% | -0.16% | – |
PRQR | Exit | PROQR THRAPEUTICS N V | $0 | – | -100,000 | -100.0% | -0.18% | – |
SNN | Exit | SMITH & NEPHEW PLCspdn adr new | $0 | – | -67,407 | -100.0% | -0.21% | – |
JUNO | Exit | JUNO THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.22% | – |
ARNI | Exit | ARNO THERAPEUTICS, INC | $0 | – | -2,034,721 | -100.0% | -0.23% | – |
KERX | Exit | KERYX BIOPHARMACEUTICALSput | $0 | – | -200,000 | -100.0% | -0.24% | – |
VBLX | Exit | VASCULAR BIOGENICS LTD | $0 | – | -500,000 | -100.0% | -0.25% | – |
FLML | Exit | FLAMEL TECHNOLOGIES SAsponsored adr | $0 | – | -644,111 | -100.0% | -0.31% | – |
ALR | Exit | ALERE INC | $0 | – | -98,000 | -100.0% | -0.31% | – |
QDEL | Exit | QUIDEL CORP | $0 | – | -142,500 | -100.0% | -0.35% | – |
MYL | Exit | MYLAN INC | $0 | – | -76,210 | -100.0% | -0.36% | – |
PRTA | Exit | PROTHENA CORP PLC | $0 | – | -247,336 | -100.0% | -0.43% | – |
HRTX | Exit | HERON THERAPEUTICS INC | $0 | – | -666,042 | -100.0% | -0.56% | – |
BDSI | Exit | BIODELIVERY SCIENCES INTL IN | $0 | – | -605,407 | -100.0% | -0.61% | – |
EPZM | Exit | EPIZYME INC | $0 | – | -432,619 | -100.0% | -0.68% | – |
ZFGN | Exit | ZAFGEN INC | $0 | – | -278,313 | -100.0% | -0.72% | – |
BDX | Exit | BECTON DICKINSON & CO | $0 | – | -80,000 | -100.0% | -0.93% | – |
VRTX | Exit | VERTEX PHARMACEUTICALS INCput | $0 | – | -100,000 | -100.0% | -1.00% | – |
VRTX | Exit | VERTEX PHARMACEUTICALS INC | $0 | – | -110,000 | -100.0% | -1.10% | – |
AGN | Exit | ALLERGAN INC | $0 | – | -82,583 | -100.0% | -1.47% | – |
OPHT | Exit | OPHTHOTECH CORP | $0 | – | -429,386 | -100.0% | -1.62% | – |
PTCT | Exit | PTC THERAPEUTICS INC | $0 | – | -671,736 | -100.0% | -2.92% | – |
NBIX | Exit | NEUROCRINE BIOSCIENCES INCput | $0 | – | -1,600,000 | -100.0% | -3.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-05-15
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13D | 2024-03-20 |
SC 13G | 2024-03-14 |
SC 13G | 2024-03-11 |
SC 13G/A | 2024-03-06 |
SC 13D/A | 2024-03-01 |
SC 13G | 2024-03-01 |
SC 13D/A | 2024-02-29 |
13F-HR/A | 2024-02-26 |
SC 13G/A | 2024-02-23 |
4 | 2024-02-21 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.